2/5 🎉Ramon Barajas Jr MD @OHSURadiology
Dr. Barajas Jr., a neuroradiologist and physician-scientist, develops and clinically translates advanced imaging biomarkers, emphasizing quantitative imaging genomics, neuroinflammation, and molecular radiotheranostics. Congratulations!👏
Barajas Lab retweeted
Great to see our review highlighted by @TheAJNR
An overview of the rapidly evolving role of focused ultrasound in neuro-oncology, from blood-brain barrier opening to therapeutic applications and imaging guidance. @PennRadiology
ajnr.org/content/47/6/1463
"This review summarizes the focused ultrasound (FUS) mechanisms and critical role of imaging modalities confirming target engagement, assessing bioeffects and outcomes, and ensuring safety. We explore future directions, including integration of liquid biopsy, AI, and outpatient-ready FUS platforms."
Barajas Lab retweeted
Our recent study showed that T1 subtraction maps can meaningfully impact quantitative assessment of enhancing tumor in pediatric brain tumors. Especially proud of first author @Sina_Bagherii, now a radiology resident at @PennRadiology @TheAJNR
pubmed.ncbi.nlm.nih.gov/4234…
Barajas Lab retweeted
Excited to share our new work on uncertainty aware multimodal risk stratification in pediatric LGG, integrating imaging, clinical, and molecular data toward individualized prognostication
Congratulations to Fadel Batal and the entire team @anahita_fathi
pubmed.ncbi.nlm.nih.gov/4252…
"Clinical Utility of 18F-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma"
doi.org/10.3174/ajnr.A9120
Barajas Lab retweeted
Neuroimaging is helping transform targeted neurosurgical care. Drs. Pavlushkov, Starkey, & Barajas review how advanced imaging guides minimally invasive approaches, including focused ultrasound, laser interstitial thermal therapy, & deep brain stimulation.
pubs.rsna.org/doi/10.1148/rg…
Barajas Lab retweeted
Big congratulations to Dr. Josh Nickerson on being elected Secretary of the American Society of Neuroradiology (ASNR), beginning the leadership path toward President.
He will be the first ASNR President from the Northwest and will help plan the 2029 Annual Meeting.
Barajas Lab retweeted
The energy in Austin was unmatched! 🎸✨ Huge thank you to everyone who joined us for the @The_ASPNR ASPNR promo party—the connections, the conversations, and the community are what make this society so special. Big thanks to the Promo Party sponsors for helping make this event possible:
📷 Guerbet, NordicNeuroLab, and Philips
We’re just getting started. Next stop: sunshine, beaches, and cutting-edge pediatric neuroradiology. ☀️🌴
Get ready to bring that same incredible energy to the coast. See you all at #ASPNR27 in Miami Beach! 🌊🧠
#PediNeuroRad #RadTwitter #MedEd #ASPNRMiamiBeach
Barajas Lab retweeted
Another fascinating session by @EMiddlebrooksMD at @TheASNR on the evolving role of 7T MRI in cerebrovascular disease with incredible case-based insights! 🧠 #ASNR26 #7TMRI – at Austin, TX
Barajas Lab retweeted
Honored to speak at #ASNR2026 on Real-World PET and Theranostics in Neuro-Oncology. Thank you Drs. @LabBarajas and @jana_ivanidze for organizing an outstanding session.
Barajas Lab retweeted
Another amazing @ASNR in the books! #ASNR26, wonderful to see friends, collaborators, and mentors across different institutions. Congratulations to Dr. Chris Hess for a fantastic ASNR! Looking forward to #ASNR27 @theasfnr @hopkinsneurorad @hopkins_rad
Barajas Lab retweeted
The Ferumoxytol Research Program, featuring Ramon Barajas and Laszlo Szidonya, was featured at OHSU Innovation Day 2026, highlighting decades of research leading to FDA approval of FERABRIGHT™ in 2025.
Watch: ohsu.edu/innovates/ohsu-inno…
Barajas Lab retweeted
Dr. Molly Thomas has a bold vision: protecting cancer patients from the dangerous inflammatory reactions that can accompany modern immunotherapy.
Her mission is to help patients stay on the treatments without suffering complications.
#OHSUResearch: news.ohsu.edu/2026/05/07/ohs…
Barajas Lab retweeted
“Dr. Druker had just had a conversation with me where he said, ‘AJ, you’re going to die of something someday, but it’s not going to be leukemia.’
It was such a relief to hear that.”
- Olympic skier AJ Kitt and a patient of Dr. Druker on Gleevec's impact: news.ohsu.edu/2026/05/11/fro…
Barajas Lab retweeted
AJ and Dr. Druker will be speaking at our May 19 Knight School event at the Knight Cancer Research Building.
Learn more: knightcancer.ticketbud.com/m…
“Dr. Druker had just had a conversation with me where he said, ‘AJ, you’re going to die of something someday, but it’s not going to be leukemia.’
It was such a relief to hear that.”
- Olympic skier AJ Kitt and a patient of Dr. Druker on Gleevec's impact: news.ohsu.edu/2026/05/11/fro…
A new $7.5 million award will increase treatment and prevention of hepatitis C, HIV and substance abuse disorders, while also addressing mental health care across 20 counties in the Beaver State. koin.com/am-extra/ohsu-expan…
Barajas Lab retweeted
"Gleevec is a game changer. It saved my life. It’s given me a second chance at life. It's allowed me to pay it forward.”
- Oregon State Representative @hi5dental, one of Dr. Brian Druker's patients: kgw.com/article/news/health/…
Barajas Lab retweeted
Congrats to the #ASNR 2026 Member-In-Training Travel Award winners! MIT Travel Award recipients receive waived in-person conference registration & $$ to cover travel expenses to the #ASNR26 meeting. Get more information and view all of the recipients here: ow.ly/3hvz50YYf8q































